Li and colleagues employed TALENs and CRISPR-cas9 to induce exon skipping, frameshift, and exon knockin in human DMD iPSCs and then differentiated the edited iPSCs into skeletal muscle cells, where dystrophin expression was observed [164]. This evidence concerns the gene DMD and Duchenne muscular dystrophy.